COMMUNIQUÉS West-GlobeNewswire

Patent Tech-AI Law NGO serving disabled people who can't afford attorney (Quantum computers meets law sector): VRN News
24/12/2024
P2P virtual law clinic aiding disabled veterans in legal actions may be the first AI-powered attorney network licensed in nearly every jurisdiction CAMBRIDGE, Mass., Dec. 24, 2024 (GLOBE NEWSWIRE) -- Earlier this month [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
24/12/2024
Déclaration de transactions sur actions propres Paris, France (24 décembre 2024, 8h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 17 décembre 2024 [...]
Aster Guardians Global Nursing Award 2025 worth US$250,000 now open for nominations worldwide
24/12/2024
Registered nurses from across the world can submit their applications through www.asterguardians.com in their preferred languages by February 10, 2025 . DUBAI, United Arab Emirates, Dec. 24, 2024 (GLOBE NEWSWIRE) -- [...]
XBiotech suspend son programme de rhumatologie
24/12/2024
Des résultats de l’étude sur la polyarthrite rhumatoïde récemment conduite soulèvent des questions AUSTIN, Texas, 24 déc. 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui qu’elle suspendait son [...]
PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million
24/12/2024
• 630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025; • Upon Potential Positive Phase 3 Data the Company Expects to Submit a New Drug Application (“ [...]
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq
23/12/2024
BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“ Neuphoria ” or the “ Company ”) is pleased to announce that its previously announced scheme of arrangement in relation [...]
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 43 rd Annual J.P. Morgan [...]
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43 rd Annual J.P. Morgan [...]
Solid Biosciences Added to the Nasdaq Biotechnology Index
23/12/2024
CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
23/12/2024
WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
Abivax Announces a Change to the Composition of its Board of Directors
23/12/2024
Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
23/12/2024
VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
23/12/2024
BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and [...]
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
23/12/2024
NOGALES, Ariz., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]
Guardion Health Sciences Announces Declaration of Cash Distribution
23/12/2024
HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash distribution (the “Distribution”) in an amount [...]
Scientists report studies showing a novel drug repairs myelin and restores nervous system function in a model of multiple sclerosis
23/12/2024
HALIFAX, Nova Scotia and SPRING, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Scientists at Dalhousie University in Halifax, and Io Therapeutics, Inc. in Spring Texas, announced today collaborative publication of data from [...]
Galimedix Therapeutics initiates pivotal Phase 2 study with GAL-101 eye drops in dry AMD
23/12/2024
Study to assess ability of GAL-101 eye drops in slowing or stopping the growth of geographic atrophy, a severe form of age-related macular degeneration Trial planned to enroll 110 patients in the US, Europe, and Israel [...]
MEDIROM Healthcare Technologies Inc. Announces November 2024 Key Performance Indicators (KPIs)
23/12/2024
Total Customers Served: 75,760 – Sales Per Customer: JPY 7,055 – Customer Repeat Ratio: 77.5% TOKYO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company [...]

Pages